Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Tourmaline Bio, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 58 | 49 | −9 |
| Shares | 26.2M | 27.4M | +1.18M (+4.5%) |
| Value | $79.7M | $77.1M | −$2.61M (−3.3%) |
New holders (4)
Institutions that held Tourmaline Bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Man Group plc | – | $141.5K | 0.00% |
| Freedom Wealth Alliance, LLC | 16,145 | $45.4K | 0.07% |
| Tower Research Capital LLC (TRC) | 962 | $2.70K | 0.00% |
| UBS Group AG | 139 | $391 | 0.00% |
Sold out (13)
Institutions that held Tourmaline Bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| HighTower Advisors, LLC | 448,359 | $1.36M |
| Scoggin Management LP | 289,608 | $880.4K |
| Jane Street Group, LLC | 91,391 | $277.8K |
| Corsair Capital Management, L.P. | 55,000 | $167.2K |
| Y-Intercept (Hong Kong) Ltd | 32,062 | $97.5K |
| Values First Advisors, Inc. | 32,009 | $97.3K |
| Occudo Quantitative Strategies LP | 28,902 | $87.9K |
| Prelude Capital Management, LLC | 15,727 | $47.8K |
| Two Sigma Securities, LLC | 14,649 | $44.5K |
| Commonwealth Equity Services, LLC | 13,000 | $40.0K |
| Acadian Asset Management LLC | 11,215 | $34.0K |
| Royal Bank of Canada | 3,440 | $10.0K |
| New York State Common Retirement Fund | 200 | $608 |